Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The iodine organification process is a key biochemical event in the thyroid gland during which inorganic iodide is oxidized and covalently linked to tyrosine residues of thyroglobulin, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT), precursors to thyroid hormones T3 and T4. This process is catalyzed by the enzyme thyroid peroxidase and is critical for normal thyroid hormone biosynthesis. Defects or inhibition of organification—such as by antithyroid drugs like thionamides—can lead to thyroid disorders including hypothyroidism and goiter. Iodine organification is not a single molecular entity but rather a stepwise biochemical process essential for endocrine health.
Inhibition of thyroid peroxidase (blocks iodine organification)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iodine organification process.